Treatment of bipolar depression with lamotrigine – rate of relapse and suicidal behaviour during 6 month follow-up treatment;Bipoláris betegek lamotrigin kezelése – Relapszus ráta és szuicid magatartás 6 hónapos követés során

Neuropsychopharmacologia Hungarica

Volumn 17, Issue 1, 2015, Pages 7-13

  Zoltán, Rihmer ^a   Xénia, Gonda ^a   János, Kálmán ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Bipolar disorder; Lamotrigine; Relapse; Remission; Suicide risk

Indexed keywords

LAMOTRIGINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; TRIAZINE DERIVATIVE;

ADD ON THERAPY; ARTICLE; BIPOLAR DEPRESSION; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RECURRENCE RISK; SUICIDAL BEHAVIOR; TREATMENT RESPONSE; ADULT; AMBULATORY CARE; BIPOLAR DISORDER; CLINICAL TRIAL; FEMALE; HUNGARY; INCIDENCE; MALE; MIDDLE AGED; PSYCHOLOGY; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADULT; AMBULATORY CARE; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNGARY; INCIDENCE; MALE; MIDDLE AGED; OFFICE VISITS; PROSPECTIVE STUDIES; RECURRENCE; SUICIDAL IDEATION; SUICIDE; SUICIDE, ATTEMPTED; TREATMENT OUTCOME; TRIAZINES;

EID: 84927611588     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ahrens B. és Müller-Oerlinghausen B. (2001): Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry, 34, 132-136.
2. American Psychiatric Association. (2002): Practice guideline for the treatment of patients with bipolar disorder (Revision). Am J Psychiatry 159, (Suppl. 1) 1-50.
3. Baldessarini, RJ, Tondo L, Davis P. és mtsai. (2006): Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipol Disord, 8: 625-639.
4. Calabrese JR, Vieta E. és Shelton MD. (2003): Latest maintenance data on lamotrigine in bipolar disorder. Eur Neuropsychopharmacol, 13, 57-66.
5. Endicott J, Nee J, Harrison W, Blumenthal R. (1993): Quality of Life Enjoyment and Satisfaction Questionnaire: A New Measure. Psychopharmacol Bull, 29(2):321-326.
6. Fountoulakis KN, Pantoula E, Siamouli M. és mtsai, (2012): Development of the Risk Assessment Suicidality Scale (RASS): A population-based study. J Affect Disord, May; 138(3): 449-57.
7. Geddes JR, Calabrese JR, Goodwin GM. (2009): Lamotrigine for treatment of bipolar depression: Independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry, 194: 4-9.
8. Ghaemi SN., Ko JK., Goodwin FK. (2002): „Cade’s Disease” and beyond: Misdiagnosis, antidepressant use, and proposed definition for bipolar spectrum disorder. Can J Psychiatry, 47, 125-134.
9. Goodwin GM. For the Consensus Group of the British Association for Psychopharmacology. (2003): Evidence-based guidelines for treating bipoloar disorder: Recommendations for the British Association for Psychopharmacology. J Psychopharmacol, 17, 149-173.
10. Goodwin GM, Bowden CL, Calabrese JR. és mtsai (2004): A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry, 65, 432-441.
11. Goodwin FK, Jamison KR. (2007): Manic-Depressive Illness. Bipolar disorders and recurrent depression. Oxford University Press, New York.
12. Grof P, Duffy A, Cavazzoni P. és mtsai. (2003): Is response to prophylactic lithium a familal trait ? J Clin Psychiatry, 63, 942-947.
13. Grunze H, Kasper S, Goodwin G. és mtsai. (2002): World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of bipolar disorders, Part I: Treatment of bipolar depression. World J Biol Psychiatry, 3, 115-124.
14. Guy W, ed. Clinical Global Impression (CGI). ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare; 1976.
15. Judd LL, Akiskal HS, Schettler PJ. és mtsai. (2002): The longterm natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry, 59, 530-537.
16. Judd LL, Akiskal HS, Schettler PJ. és mtsai. (2003): A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry, 60, 261-269.
17. Kleinman NL, Brook RA, Rajagopalan K. és mtsai (2005): Lost time, absence costs, and reduced productivity output for employers with bipolar disorder. J Occup Environ Med, 47: 1117-1124.
18. Keck, PE, Jr. és McElroy S. (2003): Redefining mood stabilization. J Affect Disord, 73, 163-169.
19. Murray CJ. és Lopez AD. (1996): The Global Burden of Disease, World Health Organization, Geneva.
20. Rihmer Z. és Kiss K. (2002): Bipolar disorders and suicidal behaviour. Bipol Disord, 4, (Suppl. 1), 21-25.
21. Rihmer Z. és Angst J. (2005): Epidemiology of bipolar disorder. In.: Handbook of Bipolar Disorder (Eds.: Kasper S. és Hirschfeld RMA.), Marcel Dekker, New York. pp. 21-35.
22. Rihmer Z. (2007): Suicide risk in mood disorders. Curr Opin Psychiatry, 20: 17-22.
23. Rihmer Z, Angst J. (2009): Mood disorders - Epidemiology. In: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 9th edition, (Eds. Sadock BJ., Sadock VA., Ruiz P.) Lippincott Williams and Wilkins, Baltimore, 2009, pp. 1645-1653.
24. Rihmer Z, Gonda X. (2013): Pharmacological prevention of suicide in patients with major mood disorders. Neurosci Biobehav Rev, 37: 2398-2403.
25. Schoeyen HK, Birkenaes AB, Vaaler AE. és mtsai. (2011): Bipolar disorder patients have similar levels of education bot lower socio-economic status than the general population. J Affect Disord, 129: 68-74.
26. Sondergard L, Lopez AG, Andersen PK. és mtsai (2008): Mood stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipol Disord, 10: 87-94.
27. Szádóczky E, Papp Z, Vitrai J. és mtsi. (2000): A hangulat- és szorongásos zavarok előfordulása a felnőtt magyar lakosság körében. Orv. Hetil, 141, 17-22.
28. Weissman MM, Bothwell S. (1976): Assessment of social adjustment by patient self-report. Arch Gen Psychiatry. 33(9):1111-5.
29. Yatham LM, Kennedy SH, Schaffer A, és mtsai. (2009): Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2009. Bipol Disord, 11: 225-255.